Hoffman Steven J, Caleo Grazia M, Daulaire Nils, Elbe Stefan, Matsoso Precious, Mossialos Elias, Rizvi Zain, Røttingen John-Arne
Global Strategy Lab, Faculty of Law, University of Ottawa, Fauteux Hall, 57 Louis Pasteur Street, Ottawa, Ontario, K1N 6N5, Canada .
Manson Unit, Médecins Sans Frontières, London, England .
Bull World Health Organ. 2015 Dec 1;93(12):867-76. doi: 10.2471/BLT.15.153171. Epub 2015 Oct 13.
Global governance and market failures mean that it is not possible to ensure access to antimicrobial medicines of sustainable effectiveness. Many people work to overcome these failures, but their institutions and initiatives are insufficiently coordinated, led and financed. Options for promoting global collective action on antimicrobial access and effectiveness include building institutions, crafting incentives and mobilizing interests. No single option is sufficient to tackle all the challenges associated with antimicrobial resistance. Promising institutional options include monitored milestones and an inter-agency task force. A global pooled fund could be used to craft incentives and a special representative nominated as an interest mobilizer. There are three policy components to the problem of antimicrobials--ensuring access, conservation and innovation. To address all three components, the right mix of options needs to be matched with an effective forum and may need to be supported by an international legal framework.
全球治理和市场失灵意味着无法确保获得具有可持续效力的抗菌药物。许多人致力于克服这些失灵情况,但他们的机构和举措缺乏充分的协调、领导和资金支持。促进全球在抗菌药物可及性和效力方面采取集体行动的选项包括建立机构、制定激励措施和调动各方利益。没有单一选项足以应对与抗菌药物耐药性相关的所有挑战。有前景的机构选项包括可监测的里程碑和一个跨部门特别工作组。可以利用一个全球统筹基金来制定激励措施,并提名一位特别代表作为利益调动者。抗菌药物问题有三个政策要素——确保可及性、保护和创新。为解决所有这三个要素,需要将正确组合的选项与一个有效的论坛相匹配,并且可能需要有一个国际法律框架的支持。